Physician profile
Jon Michael Adcock
NPI 1184688582
$4,584.99
in general payments reported to CMS, 2019-2025
43 companies · $725 in 2025
The $725 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $271 · 2021: $857 · 2022: $824 · 2023: $798 · 2024: $614 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,096 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,096.36 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $621.28 | 2019-2025 | |
| Astellas Pharma US INC | $430.06 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $385.28 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $249.88 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $234.46 | 2021-2025 | |
| Organon LLC | $213.80 | 2021-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $194.57 | 2022-2025 | |
| Hologic Sales and Service, LLC | $187.04 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Myovant Sciences INC. | $155.39 | 2021-2022 | |
| Millicent US INC | $150.44 | 2024-2025 | Intrarosa |
| Shield Therapeutics INC | $141.94 | 2023-2025 | Accrufer |
| Duchesnay USA Incorporated | $137.52 | 2019 | |
| Evofem Biosciences, INC. | $121.24 | 2021 | |
| Amgen INC. | $118.00 | 2019-2022 | |
| Myriad Women'S Health, INC. | $115.10 | 2023 | Risk Score |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $102.48 | 2020-2025 | Slynd |
| Aspira Women'S Health INC | $99.69 | 2022 | |
| Scynexis, INC. | $80.92 | 2021-2022 | |
| Channel Medsystems, INC. | $73.50 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.58 | 2020-2025 | Relistor |
| Lupin INC. | $68.68 | 2019-2021 | |
| Minerva Surgical, INC | $66.83 | 2020-2023 | |
| Therapeuticsmd, INC. | $60.73 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $51.55 | 2019 | |
| Exact Sciences Corporation | $51.48 | 2023-2025 | Cologuard Collection Kit |
| Coopersurgical, INC. | $50.03 | 2020-2021 | |
| Convatec INC. | $42.80 | 2022-2023 | |
| Mylan Pharmaceuticals INC. | $38.34 | 2019-2021 | |
| Kerecis Limited | $32.91 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sage Therapeutics, LLC | $31.63 | 2023-2025 | Zurzuvae |
| Novo Nordisk INC | $31.21 | 2025 | |
| Intuitive Surgical, INC. | $22.84 | 2024 | |
| Coloplast Corp | $18.50 | 2025 | |
| Meditrina | $17.50 | 2025 | |
| Conmed Corporation | $15.90 | 2023 | Visiclear, Airseal |
| Merck Sharp & Dohme LLC | $14.12 | 2020 | |
| Ethicon US, LLC | $13.66 | 2020 | |
| Medicem INC. | $12.66 | 2020 | |
| Urovant Sciences INC | $12.33 | 2022 | |
| Sanara Medtech INC. | $11.89 | 2021 | |
| Axonics, INC. | $11.85 | 2022 | |
| Covidien LP | $11.78 | 2019 | |
| Allegis Pharmaceuticals, LLC | $10.60 | 2023 | Urimar-T Caps |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Adcock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.